Registry Following Patients With Acute Coronary Syndrome in the Emergency Department
Studies blood and biomarker samples from adults with heart attack symptoms arriving at emergency care.
Key facts
- Who runs it
- University Hospital Heidelberg
- Where
- Heidelberg, GermanySee the site
- Trial code
- Registry title
- Myocardial Infarction Registry
- Status
- Recruiting
- People taking part
- 2,500 people, planned
- Started
- 1 Aug 2014
- Expected to end
- 31 Dec 2030
- Type of study
- Observational
- Treatments tested
- no intervention is intended.
- Record updated
- 14 November 2023
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who come to the cardiology emergency department at Heidelberg University Hospital with symptoms of acute coronary syndrome or a raised troponin level.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- Symptoms of acute coronary syndrome or a troponin increase (hs-TnT >14 ng/L).
- Biomarker or test result
- Troponin increase (hs-TnT >14 ng/L), or symptoms of acute coronary syndrome.
Main reasons for not taking part
- Cannot give informed consent (mental illness or dementia)
- Pregnant or breastfeeding
- Acute conditions that need immediate treatment, such as cardiogenic shock
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- The study will include consecutive patients who present to the cardiology emergency department at Heidelberg University Hospital with symptoms of acute coronary syndrome or a troponin increase (hs-TnT >14 ng/L). Additional inclusion criteria are a minimum age of 18 years and providing informed consent through written consent to participate in the study. The following medical conditions are intended to be distinguished from one another:
- Acute myocardial infarction
- Unstable angina pectoris
- Myocarditis
- Heart failure
- Cardiomyopathies
- Pulmonary embolism
- Renal insufficiency
- Supraventricular and ventricular tachycardias
- Hypertensive crisis
- Non-cardiac chest pain
Where in Germany
- University Hospital of HeidelbergHeidelberg, GermanyContact: Mustafa Yildirim, MDTaking people
About the trial
What the trial wants to find out
The single-center MIR-registry was created to assess real-world prevalence, demographic characteristics and management of patients with acute coronary syndrome presenting in the emergency department (ED) of University of Heidelberg.
The group in the trial
- MIR (Myocardial Infarction Registry)
All patients presenting to the Emergency Department with suspected acute coronary syndrome
Treatment: no intervention is intended.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Cardiac Biochemical and Omics-based Biomarkers in Patients Presenting Symptoms of Acute Coronary Syndrome in the Emergency Department (ACS Registry)
- Plain-language title
- Registry Following Patients With Acute Coronary Syndrome in the Emergency DepartmentGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 14 November 2023